WO2002092779A3 - Method for enriching tissues in long chain polyunsaturated fatty acids - Google Patents

Method for enriching tissues in long chain polyunsaturated fatty acids Download PDF

Info

Publication number
WO2002092779A3
WO2002092779A3 PCT/US2002/015747 US0215747W WO02092779A3 WO 2002092779 A3 WO2002092779 A3 WO 2002092779A3 US 0215747 W US0215747 W US 0215747W WO 02092779 A3 WO02092779 A3 WO 02092779A3
Authority
WO
WIPO (PCT)
Prior art keywords
fatty acids
long chain
polyunsaturated fatty
tissues
enriching
Prior art date
Application number
PCT/US2002/015747
Other languages
French (fr)
Other versions
WO2002092779A2 (en
Inventor
Marc E Surette
Kenneth M Tramposch
Original Assignee
Pilot Therapeutics Inc
Marc E Surette
Kenneth M Tramposch
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pilot Therapeutics Inc, Marc E Surette, Kenneth M Tramposch filed Critical Pilot Therapeutics Inc
Priority to AU2002309931A priority Critical patent/AU2002309931A1/en
Publication of WO2002092779A2 publication Critical patent/WO2002092779A2/en
Publication of WO2002092779A3 publication Critical patent/WO2002092779A3/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/201—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having one or two double bonds, e.g. oleic, linoleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/02—Algae
    • A61K36/03—Phaeophycota or phaeophyta (brown algae), e.g. Fucus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/30—Boraginaceae (Borage family), e.g. comfrey, lungwort or forget-me-not
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

A method is disclosed for the in vivo enrichment of mammalian tissues in long chain n-3 polyunsaturated fatty acids by administering a source of stearidonic acid, preferably Echium oil, in an amount sufficient to effect such enrichment.
PCT/US2002/015747 2001-05-17 2002-05-17 Method for enriching tissues in long chain polyunsaturated fatty acids WO2002092779A2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002309931A AU2002309931A1 (en) 2001-05-17 2002-05-17 Method for enriching tissues in long chain polyunsaturated fatty acids

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29158401P 2001-05-17 2001-05-17
US60/291,584 2001-05-17

Publications (2)

Publication Number Publication Date
WO2002092779A2 WO2002092779A2 (en) 2002-11-21
WO2002092779A3 true WO2002092779A3 (en) 2003-03-13

Family

ID=23120911

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2002/015747 WO2002092779A2 (en) 2001-05-17 2002-05-17 Method for enriching tissues in long chain polyunsaturated fatty acids

Country Status (2)

Country Link
AU (1) AU2002309931A1 (en)
WO (1) WO2002092779A2 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095953A (en) * 2017-06-12 2017-08-29 张伟伟 A kind of Chinese medicine for treating pregnant depression

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA04008711A (en) 2002-03-08 2004-12-13 Monsanto Technology Llc Treatment and prevention of inflammatory disorders.
CA2586310C (en) 2004-11-04 2013-09-24 Monsanto Technology Llc Seed oil compositions
WO2007066216A2 (en) * 2005-12-09 2007-06-14 Institut National De La Sante Et De La Recherche Medicale (Inserm) Fatty acids profile correlated to the propensity or risk of breast cancer
EP1991217A2 (en) * 2006-03-03 2008-11-19 Monsanto Technology LLC Stearidonic acid for improving cardiovascular health
PT1835014E (en) 2006-03-14 2015-08-31 Oilseeds Biorefinery Corp Oil extraction using fatty acid alkyl esters
ES2541911T3 (en) 2006-06-08 2015-07-28 Iams Europe B.V. Use of at least one polyphenol to stimulate eye health
WO2009099886A1 (en) * 2008-01-31 2009-08-13 Monsanto Technology Llc Methods of improving dha deposition and related function and/or development
US20110251276A1 (en) * 2009-01-05 2011-10-13 Calanus As Biological oil composition, formulations comprising the oil composition, and use thereof to prevent or treat cardiovascular disease
KR101938055B1 (en) 2017-04-05 2019-01-14 성균관대학교산학협력단 A composition for treating, improving and preventing of artheriosclerosis comprising Gracilariopsis chorda ohmi extract or Gracilariopsis chorda ohmi fraction

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178873A (en) * 1990-06-06 1993-01-12 Efamol Holdings Plc Essential fatty acid treatment
WO1999033355A2 (en) * 1997-12-23 1999-07-08 N.V. Nutricia Fat blend
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
WO2001017517A2 (en) * 1999-09-10 2001-03-15 Monsanto Technology, Llc Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer
US6331568B1 (en) * 1996-10-11 2001-12-18 Scotia Holdings Plc. Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5178873A (en) * 1990-06-06 1993-01-12 Efamol Holdings Plc Essential fatty acid treatment
US6331568B1 (en) * 1996-10-11 2001-12-18 Scotia Holdings Plc. Pharmaceutical preparation comprising eicosapentaenoic acid and/or stearidonic acid
WO1999033355A2 (en) * 1997-12-23 1999-07-08 N.V. Nutricia Fat blend
US6107334A (en) * 1998-02-23 2000-08-22 Wake Forest University Dietary control of arachidonic acid metabolism
WO2001017517A2 (en) * 1999-09-10 2001-03-15 Monsanto Technology, Llc Use of g(a)-linolenic acid metabolites in the manufacture of a medicament for the treatment or prevention of cancer

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107095953A (en) * 2017-06-12 2017-08-29 张伟伟 A kind of Chinese medicine for treating pregnant depression

Also Published As

Publication number Publication date
WO2002092779A2 (en) 2002-11-21
AU2002309931A1 (en) 2002-11-25

Similar Documents

Publication Publication Date Title
IL160012A0 (en) Modifying the fatty acid composition of cell membranes of organs and tissues
BRPI0418921A (en) use of polyunsaturated fatty acids, nutritional composition, and use of a
IS2180B (en) A pharmaceutical composition containing eicosapentaenoic acid and / or steridonic acid
EP1682567A4 (en) Delta12 desaturases suitable for altering levels of polyunsaturated fatty acids in oleaginous yeast
MY162133A (en) Nutritional supplement containing long-chain polyunsaturated fatty acids
DE60323354D1 (en) COMPOSITIONS CONTAINING SHORT AND LOW-CHAINED FATTY ACIDS, AND METHOD FOR THEIR USE
WO2004078166A3 (en) Use of omega-3-fatty acids in the treatment of diabetic patients
EP2392664A3 (en) Production of polyunsaturated fatty acids in oleaginous yeasts
WO2007136671A3 (en) Delta5 desaturase and its use in making polyunsaturated fatty acids
NO20026093L (en) Therapeutic combinations of fatty acids
CY1113437T1 (en) COMPOSITIONS WITH HEALTH AND NUTRITION CHARACTERISTICS CONTAINING DISTRIBUTED FATS AND PLANTS
WO2002081668A3 (en) Desaturase genes and uses thereof
WO2008129358A8 (en) Oil producing microbes and methods of modification thereof
EA201000400A1 (en) SOLID FATTY COMPOSITIONS CONTAINING POLYUNSATURATED FATTY ACIDS, AND METHODS FOR THEIR RECEIVING AND USE
ATE292460T1 (en) COMPOSITIONS CONTAINING ACTIVE STILBENOID COMPOUNDS FOR LOWERING TRIGLYCERIDE LEVELS
DE60132508D1 (en) Compositions containing phytosterol and policosanol esters of fatty acids for lowering cholesterol and triglyceride levels
WO2002092779A3 (en) Method for enriching tissues in long chain polyunsaturated fatty acids
BR0309089A (en) Dietary Methods for Performance Improvement in Dogs
SG149825A1 (en) Body taste improver comprising long-chain highly unsaturated fatty acid and/or ester thereof
ATE473285T1 (en) METHOD FOR PRODUCING GAMMA-LINOLENIC ACID FROM A CILIATES CULTURE BY ADDING SUITABLE PRECURSOR MOLECULES TO THE CULTURE MEDIUM
TW200503634A (en) Method for the production of fatty acids having a low trans-fatty acid content
MXPA01007680A (en) Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (hode) or the esters thereof from a mixture containing linoleic acid or the esters thereof.
FI980961A (en) Method for Increasing the Conjugated Linoleic Acid Content of Milk and / or Tissue Fat in a Ruminant
SE9903915D0 (en) Cholesterol lowering and blood fat lowering composition
DE60329588D1 (en) USE OF EPA AND DHA FOR SECONDARY PREVENTION OF STROKE

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP

WWW Wipo information: withdrawn in national office

Country of ref document: JP